BC Week In Review | Apr 13, 2009
Clinical News

AVantage A/H5N1 Flu Test regulatory update

FDA granted 510(k) clearance for Arbor Vita's AVantage A/H5N1 Flu Test to detect H5N1 avian influenza A virus. The company plans to launch the diagnostic, which detects influenza virus non-structural protein 1 (NS-1) from nose...
BC Week In Review | Mar 31, 2008
Clinical News

AVC Dx-2: Preliminary pilot trial data

Preliminary data showed that the company’s rapid H5N1 flu antigen assay test identified 0 false positives against a clinical panel of 28 isolates from avian and human sources. Of the 28 H5N1 cultures tested, 26...
Items per page:
1 - 2 of 2